MX9202512A - Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. - Google Patents

Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus.

Info

Publication number
MX9202512A
MX9202512A MX9202512A MX9202512A MX9202512A MX 9202512 A MX9202512 A MX 9202512A MX 9202512 A MX9202512 A MX 9202512A MX 9202512 A MX9202512 A MX 9202512A MX 9202512 A MX9202512 A MX 9202512A
Authority
MX
Mexico
Prior art keywords
virus
cultivation
cells infected
vaccines
recombinant avipox
Prior art date
Application number
MX9202512A
Other languages
English (en)
Inventor
Georges Thiry
Didier Colau
Catherine De Wannemaeker
Daniel Malarme
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of MX9202512A publication Critical patent/MX9202512A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

El invento se refiere a un virus de Avipox recombinante derivado de unacapa atenuada del virus de Avipox y que comprende en una parte no esencialde su genoma al menos una secuencia de ADN que codifica la totalidad oparte de una proteína heteróloga al virus de Avipox, estando constituídala parte no esencial del genoma por una región intergénica de la TIR(región de repetición terminal inversa, en inglés " terminal invertedrepeat") Igualmente el invento se refiere al cultivo de células infectadaspor este virus, a las vacunas que contienen este virus Avipox recombinantey a la utilización de este virus como vector capaz de expresar latotalidad o parte de una proteína heteróloga al virus.
MX9202512A 1991-05-27 1992-05-27 Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. MX9202512A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9100507A BE1004877A3 (fr) 1991-05-27 1991-05-27 Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.

Publications (1)

Publication Number Publication Date
MX9202512A true MX9202512A (es) 1995-01-31

Family

ID=3885526

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202512A MX9202512A (es) 1991-05-27 1992-05-27 Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus.

Country Status (23)

Country Link
EP (1) EP0517292B1 (es)
JP (1) JP3411307B2 (es)
KR (1) KR100244601B1 (es)
CN (1) CN1055501C (es)
AR (1) AR248045A1 (es)
AT (1) ATE189480T1 (es)
AU (1) AU656185B2 (es)
BE (1) BE1004877A3 (es)
BR (1) BR9202024A (es)
CA (1) CA2069594A1 (es)
DE (1) DE69230627T2 (es)
DK (1) DK0517292T3 (es)
ES (1) ES2145000T3 (es)
HU (1) HU215531B (es)
IE (1) IE921686A1 (es)
IL (1) IL101780A (es)
MX (1) MX9202512A (es)
NZ (1) NZ242620A (es)
PT (1) PT517292E (es)
RU (1) RU2130971C1 (es)
SG (1) SG49876A1 (es)
TW (1) TW288048B (es)
ZA (1) ZA923321B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06509235A (ja) * 1991-07-26 1994-10-20 ヴァイロジェネティクス　コーポレイション 伝染性ファブリキウス嚢病ウイルス組換えポックスウイルスワクチン
ES2236684T3 (es) * 1992-01-13 2005-07-16 Virogenetics Corporation Vacuna del virus vaccinia recombinante procedente del virus de la enfermedad de marek.
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
JP2005517639A (ja) 2001-11-30 2005-06-16 イシス イノベーション リミテッド ワクチン
JP4895505B2 (ja) * 2002-05-16 2012-03-14 バヴァリアン・ノルディック・アクティーゼルスカブ 変異ワクシニアウイルスアンカラ（ｍｖａ）ゲノム中の挿入部位としての遺伝子間領域
AU2004291024B2 (en) * 2003-02-20 2009-09-17 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Novel insertion sites in pox vectors
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
PE20141482A1 (es) 2011-11-30 2014-11-08 Merial Ltd Vectores recombinantes de hvt que expresan antigenos de patogenos de aves y sus usos
EP2845904A1 (en) 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
EP3263129A1 (en) 2016-06-29 2018-01-03 Ceva Sante Animale Duck enteritis virus and the uses thereof
CN117357642A (zh) 2016-12-14 2024-01-09 勃林格殷格翰动物保健美国公司 表达禽病原体的多种抗原的重组hvt载体及其用途
BR112021012434A2 (pt) 2018-12-27 2021-09-28 Ceva Sante Animale Vírus recombinantes e usos dos mesmos
MA58717A1 (fr) 2020-06-17 2023-06-28 Boehringer Ingelheim Vetmedica Gmbh Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
EP0353851B1 (en) * 1988-06-24 1994-01-19 Btg International Limited Fowlpox virus non-essential regions
EP0419666A4 (en) * 1988-12-29 1991-05-15 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus
AU643216B2 (en) * 1989-05-30 1993-11-11 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form

Also Published As

Publication number Publication date
JP3411307B2 (ja) 2003-05-26
CA2069594A1 (fr) 1992-11-28
AR248045A1 (es) 1995-05-31
CN1069068A (zh) 1993-02-17
EP0517292A1 (fr) 1992-12-09
HU215531B (hu) 2000-05-28
IL101780A0 (en) 1992-12-30
TW288048B (es) 1996-10-11
BR9202024A (pt) 1993-01-19
BE1004877A3 (fr) 1993-02-16
EP0517292B1 (fr) 2000-02-02
NZ242620A (en) 1993-09-27
ATE189480T1 (de) 2000-02-15
JPH05244939A (ja) 1993-09-24
DK0517292T3 (da) 2000-05-08
PT517292E (pt) 2000-06-30
IL101780A (en) 2000-12-06
DE69230627T2 (de) 2000-09-28
RU2130971C1 (ru) 1999-05-27
CN1055501C (zh) 2000-08-16
HUT62331A (en) 1993-04-28
AU656185B2 (en) 1995-01-27
ES2145000T3 (es) 2000-07-01
SG49876A1 (en) 2002-04-16
AU1632392A (en) 1992-12-03
KR100244601B1 (ko) 2000-03-02
KR920021706A (ko) 1992-12-18
DE69230627D1 (de) 2000-03-09
IE921686A1 (en) 1992-12-02
HU9201746D0 (en) 1992-08-28
ZA923321B (en) 1993-01-27

Similar Documents

Publication Publication Date Title
MX9202512A (es) Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus.
ES2061708T3 (es) Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus.
ES2664505T3 (es) Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
ES2061996T3 (es) Regiones no esenciales de avipoxvirus.
ES2140418T3 (es) Flavivirus quimericos y/o flavivirus de crecimiento restringido.
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
ATE212671T1 (de) Rekombinierte virale nukleinsäure aus pflanzen
DE69434820D1 (de) Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis
SG55095A1 (en) Viruses and their use as a vaccine against feline infectious peritonitis virus disease
CO4480038A1 (es) Virus de inmunodeficiencia felina geneticamente alterados y vacuna eficaz contra las infecciones del virus de inmunodeficiencia felina
KR930701610A (ko) 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학분야에서 이들을 사용하는 방법
DK0831899T3 (da) Rekombinant koppevirus-calicivirus-præparater og anvendelser
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
IL146191A0 (en) Viral expression vectors
ATE237629T1 (de) Rekombinanter virus der marek-krankheit, verfahren zur herstellung dieses viruses und diesen enthaltender impfstoff
BR9508645B1 (pt) seqÜÊncia de nucleotÍdeos isolada compreendendo o gene s fipv tendo uma seqÜencia de nucleotÍdeos da cepa 79-1146 fipv, bem como polipeptÍdeo, vacina e composiÇço compreendendo a mesma.
DE3789545D1 (de) Impfstoff bestehend aus einem Virusvektor und Rekombinanten-DNS, die das p25-Protein vom AIDS-Virus kodieren.
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
DE69132717T2 (de) Hepatitis-a-impfstoff
TH33841A (th) รีคอมบิแนนท์เอวิพอคซ์ไวรัส การเพาะเลี้ยงเซลล์ที่ติดเชื้อไวรัสนี้ และวัคซีนสำหรับสัตว์ปีกที่อนุพัทธ์จากไวรัสนี้
TH22679B (th) การเอ็กซ์เพรสโพลีเพพไทด์ของไวรัสก่อโรคทางระบบหายใจที่แพร่พันธุ์ได้ในสุกรในเซลล์เดียวกัน
TH33841EX (th) รีคอมบิแนนท์เอวิพอคซ์ไวรัส การเพาะเลี้ยงเซลล์ที่ติดเชื้อไวรัสนี้ และวัคซีนสำหรับสัตว์ปีกที่อนุพัทธ์จากไวรัสนี้